SenesTech Inc (SNES)
NASDAQ:SNES
Want to see SNES full AI Analyst Report?
Top Page
SenesTech
(NASDAQ:SNES)
Select Model
Select Model
Rating:50Neutral
Price Target:
$1.50
▼(-6.25% Downside)
Action:Reiterated
Date:06/11/26
The score is held back most by weak financial performance (deep losses and ongoing cash burn despite improving gross margin) and a valuation profile constrained by negative earnings. Technicals are mixed-to-neutral, while the latest earnings call provides the main support via improving commercial KPIs and management’s focus on scaling recurring revenue and optimizing costs.
Positive Factors
Proprietary non‑lethal product
SenesTech’s core proprietary fertility-control approach creates a distinct, defensible product niche versus toxicants. A differentiated, non-lethal solution fits municipal and commercial public‑health mandates, supports recurring program purchases, and builds a long-term commercial moat in pest management.
Negative Factors
Persistent cash burn
Ongoing negative operating and free cash flow materially increases financing dependency and limits flexibility to invest in growth or endure setbacks. Continued cash burn elevates dilution or debt risk and makes multi‑quarter execution and scale‑up contingent on securing new capital or rapid margin conversion.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary non‑lethal product
SenesTech’s core proprietary fertility-control approach creates a distinct, defensible product niche versus toxicants. A differentiated, non-lethal solution fits municipal and commercial public‑health mandates, supports recurring program purchases, and builds a long-term commercial moat in pest management.
Read all positive factors
SenesTech (SNES) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$8.96M
Dividend YieldN/A
Average Volume (3M)66.03K
Price to Earnings (P/E)―
Beta (1Y)1.83
Revenue Growth15.67%
EPS Growth75.35%
CountryUS
Employees23
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-1.89
Shares Outstanding5,303,426
10 Day Avg. Volume49,700
30 Day Avg. Volume66,031
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)7.33
Price to Sales (P/S)31.57
P/FCF Ratio-11.91
Enterprise Value/Market Cap0.56
Enterprise Value/Revenue2.24
Enterprise Value/Gross Profit3.62
Enterprise Value/Ebitda-0.75
Forecast
1Y Price Target
$10.00Price Target Upside525.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-1.61
Revenue Forecast (FY)$2.24M
SenesTech Business Overview & Revenue Model
Company Description
SenesTech, Inc. focuses on developing innovative technologies to manage pest animal populations by inhibiting their fertility. The company's primary offering is ContraPest, a specially formulated liquid bait that effectively reduces the breeding c...
How the Company Makes Money
SenesTech makes money primarily by selling its rodent fertility-control products (notably its branded rat fertility-control bait) through commercial channels. Revenue is generated from product sales to distributors, pest-management companies, and ...
SenesTech Earnings Call Summary
Earnings Call Date:May 12, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 06, 2026
Earnings Call Sentiment Positive
The call presented multiple strong operational and commercial progress points—record direct-to-consumer, subscription and gross margin metrics, significant April e-commerce momentum, and B2B growth—while acknowledging near-term disruptions from the Amazon transition, one-time restructuring/legal costs (~$443k), modest overall quarterly revenue growth (+2%), and an ongoing adjusted EBITDA loss. Management emphasized discipline, measurable KPIs, and a clear plan to convert early momentum into repeatable revenue and improved cash flow. The tone is constructive and forward-looking but tempered by early-stage execution risk and the need to sustain recent gains over subsequent quarters.Positive Updates
Direct-to-Consumer Revenue Growth
Direct-to-consumer revenue increased 42% year-over-year to a record $194,000 in Q1 2026 (from $137,000 prior year), driven by bringing Amazon operations in-house and D2C initiatives.
Negative Updates
Modest Overall Revenue Growth for the Quarter
Total revenue for Q1 was $493,000, up only 2% year-over-year from $485,000, reflecting short-term disruption from the Amazon transition and a still-small top-line base.
Read all updates
Q1-2026 Updates
Positive
Negative
Direct-to-Consumer Revenue Growth
Direct-to-consumer revenue increased 42% year-over-year to a record $194,000 in Q1 2026 (from $137,000 prior year), driven by bringing Amazon operations in-house and D2C initiatives.
Read all positive updates
Company Guidance
Management's guidance emphasized continued quarter‑over‑quarter growth and the likelihood of record revenues as the company scales direct‑to‑consumer and B2B initiatives; Q1 revenue was $493,000 (+2% YoY) with direct‑to‑consumer sales $194,000 (+42% YoY) and subscription revenue $56,000 (+44% YoY) while subscriber counts rose >50% in the quarter, B2B revenue was $298,000 (+57% YoY), gross profit was $338,000 (+8% YoY) and gross margin hit a company record 68.6% (vs. 64.5%); management completed the Amazon transition in mid‑March and pointed to April as an early proof point with e‑commerce sales ≈$146,000 (+163% YoY, +47% vs. March), Amazon retail ≈$96,000 and senestech.com ≈$50,000, April subscription revenue ≈$36,000 (+198% YoY) with subscription customers +109%, noted ~$443,000 of one‑time Q1 charges (pro forma adjusted EBITDA loss $1.6M vs $1.5M prior) and $6.8M cash giving runway into Q3 2027, and reiterated plans to optimize SG&A, prioritize recurring revenue, improve conversion and pursue disciplined B2B opportunities.SenesTech Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
46
Neutral
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.23M | 2.22M | 1.86M | 1.19M | 1.02M | 576.00K |
| Gross Profit | 1.38M | 1.39M | 1.00M | 539.00K | 464.00K | 220.00K |
| EBITDA | -6.63M | -6.23M | -6.01M | -7.57M | -9.51M | -7.95M |
| Net Income | -6.78M | -6.38M | -6.18M | -7.71M | -9.70M | -8.27M |
Balance Sheet | ||||||
| Total Assets | 11.06M | 12.84M | 3.28M | 7.29M | 6.78M | 11.50M |
| Cash, Cash Equivalents and Short-Term Investments | 6.80M | 8.57M | 1.31M | 5.39M | 4.78M | 9.33M |
| Total Debt | 2.63M | 2.68M | 262.00K | 406.00K | 359.00K | 555.00K |
| Total Liabilities | 3.36M | 3.27M | 767.00K | 942.00K | 1.50M | 1.47M |
| Stockholders Equity | 7.70M | 9.57M | 2.51M | 6.35M | 5.28M | 10.04M |
Cash Flow | ||||||
| Free Cash Flow | -6.22M | -5.89M | -6.12M | -7.71M | -8.75M | -7.88M |
| Operating Cash Flow | -6.12M | -5.75M | -6.03M | -7.57M | -8.58M | -7.78M |
| Investing Cash Flow | -66.00K | -1.10M | -56.00K | -149.00K | -170.00K | -99.00K |
| Financing Cash Flow | 11.34M | 13.12M | 2.00M | 8.34M | 4.20M | 13.56M |
SenesTech Technical Analysis
Positive
1.60
Price Trends
1.64
Positive
1.81
Negative
2.62
Negative
Market Momentum
<0.01
Positive
50.84
Neutral
71.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNES, the sentiment is Positive. The current price of 1.6 is below the 20-day moving average (MA) of 1.69, below the 50-day MA of 1.64, and below the 200-day MA of 2.62, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 50.84 is Neutral, neither overbought nor oversold. The STOCH value of 71.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SNES.
SenesTech Risk Analysis
SenesTech disclosed 31 risk factors in its most recent earnings report. SenesTech reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
SenesTech Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | $80.88M | 98.24 | 2.11% | ― | 7.82% | -64.59% | |
52 Neutral | $76.89M | -99.14 | -1.07% | 1.33% | 5.55% | -120.30% | |
50 Neutral | $8.96M | -1.31 | -77.79% | ― | 15.67% | 75.35% | |
47 Neutral | $39.71M | -3.20 | 196.04% | ― | -95.28% | 18.96% | |
43 Neutral | $5.35M | -0.09 | -43.37% | ― | 61.85% | 49.02% |
* Basic Materials Sector Average
SNES
SenesTech
1.69
-1.11
-39.64%
FSI
Flexible Solutions International
6.35
1.96
44.65%
GURE
Gulf Resources
3.87
-2.11
-35.28%
NTIC
Northern Technologies International
8.10
0.87
11.99%
LOOP
Loop Industries
0.82
-0.80
-49.38%
CNEY
CN Energy Group
0.76
-2.06
-72.99%
SenesTech Corporate Events
Executive/Board ChangesShareholder Meetings
SenesTech Shareholders Approve Directors, Compensation and Equity Plan
Positive
Jun 10, 2026
On June 9, 2026, SenesTech, Inc. held its 2026 annual meeting of stockholders, at which shareholders elected Jake S. Leach and Joshua M. Moss as Class I directors to serve three-year terms ending with the 2029 annual meeting. Investors also approv...
Business Operations and StrategyExecutive/Board Changes
SenesTech Appoints Michael Edell as New CEO and President
Positive
May 7, 2026
On May 6, 2026, SenesTech, Inc. appointed former Interim Chief Operating Officer Michael Edell as its new president and chief executive officer, succeeding Joel L. Fruendt, and simultaneously named him to the board as a Class III director with a t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.